Subsequent next generation sequencing looking for myeloid neoplasm associated gene mutations showed a concurrent JAK2 V617F mutation with a low allele variance frequency of 8%, causing this case classification to be more challenging. Here, JAK2 is linked to myeloid neoplasm.